The purpose of this study is to determine the transcriptional signature of Notch Inhibition by testing hair and blood samples on healthy male volunteers who have received MK0752 vs placebo for possible future biomarkers in the treatment of cancer or Alzheimers Disease
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Enrollment
30
Single dose MK0752 capsules, 1000 mg: there will be a 7-day washout period between treatments.
Single dose MK0752 capsules, 350 mg: there will be a 7-day washout period between treatments.
Single dose placebo capsules: there will be a 7-day washout period between treatments.
To evaluate the existing Notch response signature using plucked hair follicle profiling data from health young male volunteers given 1000 mg MK0752 and 350 mg MK0752.
Time frame: 8.5 hours post dose.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.